Updated Good Publication Practice (GPP3) guidelines have been published in the Annals of Internal Medicine. The updated guidelines include a new section on data sharing, and continue to call for all clinical trials to be reported in a complete, accurate, balanced, transparent, and timely manner.

The guidelines are designed to help individuals and organisations maintain ethical and legal standards when communicating research sponsored by pharmaceutical, medical device, diagnostics, or biotechnology companies.

The full Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3 guidelines are available here. A great blog about the history of the guidlines by Liz Wager, contributor to the guidelines, is available here: GPP3—thoughts on becoming a guideline grandmother.